Cargando…
Combined RNA interference and gene replacement therapy targeting MFN2 as proof of principle for the treatment of Charcot–Marie–Tooth type 2A
Mitofusin-2 (MFN2) is an outer mitochondrial membrane protein essential for mitochondrial networking in most cells. Autosomal dominant mutations in the MFN2 gene cause Charcot–Marie–Tooth type 2A disease (CMT2A), a severe and disabling sensory-motor neuropathy that impacts the entire nervous system....
Autores principales: | Rizzo, Federica, Bono, Silvia, Ruepp, Marc David, Salani, Sabrina, Ottoboni, Linda, Abati, Elena, Melzi, Valentina, Cordiglieri, Chiara, Pagliarani, Serena, De Gioia, Roberta, Anastasia, Alessia, Taiana, Michela, Garbellini, Manuela, Lodato, Simona, Kunderfranco, Paolo, Cazzato, Daniele, Cartelli, Daniele, Lonati, Caterina, Bresolin, Nereo, Comi, Giacomo, Nizzardo, Monica, Corti, Stefania |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676309/ https://www.ncbi.nlm.nih.gov/pubmed/38007410 http://dx.doi.org/10.1007/s00018-023-05018-w |
Ejemplares similares
-
Charcot–Marie–Tooth disease type 2F associated with biallelic HSPB1 mutations
por: Abati, Elena, et al.
Publicado: (2021) -
MFN2-related Charcot-Marie-Tooth Disease with Atypical Ocular Manifestations
por: Nan, Haitian, et al.
Publicado: (2021) -
Clinical and genetic features of a cohort of patients with MFN2-related neuropathy
por: Abati, Elena, et al.
Publicado: (2022) -
Multiple respiratory complications in a patient with Charcot-Marie-Tooth disease with MFN2 mutation
por: Sano, Tomoya, et al.
Publicado: (2022) -
Spinal muscular atrophy phenotype is ameliorated in human motor neurons by SMN increase via different novel RNA therapeutic approaches
por: Nizzardo, Monica, et al.
Publicado: (2015)